AHED MAKHOUL: Open Payments
NPI 1316301302 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $845
Food & beverage: $583Education: $262
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $343 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $117 |
| Incyte Corporation | 1 | $97 |
| SEAGEN INC. | 1 | $88 |
| Astellas Pharma US Inc | 1 | $75 |
Products named: RYBREVANT, LYNOZYFIC, VECTIBIX, DARZALEX, Jakafi.
Industry payments across OH — which companies pay providers there.
